Research Impact

h-index

N/A

Research impact score

Publications

Total publications

Trial Results

Published trial results

Citations

Total citations

Drug Portfolio

MIXED(3)

DRUG(1)

Irinotecan Injection [Camptosar]

Nivolumab 10 MG/ML Intravenous Solution [OPDIVO]

1 trial

phase_1

augusta-university

4 unique interventions2 categories

Analytics

Trial Phases

Phase 12

Trial Status

Terminated2

Role Distribution

Principal Investigator2

PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT04173338Phase 1Terminated

Cabozantinib With Pemetrexed in Advanced Non-small Cell Lung Cancer, Urothelial Cancer and Malignant Mesothelioma

Malignant MesotheliomaNon Small Cell Lung CancerNon-squamous Non-small-cell Lung Cancer+1 more

PrincipalinvestigatorStart date: 2020-01-23

NCT04173325Phase 1Terminated

Feasibility and Safety Study of Nivolumab With Irinotecan for Small Cell Lung Cancer

Small Cell Lung CarcinomaSmall-cell Lung Cancer

PrincipalinvestigatorStart date: 2020-01-06

Research Network

Collaboration Network

1 collaborators·0 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Mesothelioma, Malignant1 Carcinoma, Non-Small-Cell Lung1 Non-squamous Non-small-cell Lung Cancer1 Small Cell Lung Carcinoma1 Urothelial Carcinoma1

Affiliations

Augusta University Georgia Cancer Center

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

You Lu, MD

West China Hospital

18 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungNon-squamous Non-small-cell Lung CancerSmall Cell Lung Carcinoma

Similarity Score18%

Arun Rajan, M.D.

National Cancer Institute (NCI)

17 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungSmall Cell Lung Carcinoma

Similarity Score12%

Hui Liu, professor

Sun yat-sen universtiy cancer center

15 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungSmall Cell Lung Carcinoma

Similarity Score12%

Yongchang Zhang, MD

Hunan Cancer Hospital

27 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungSmall Cell Lung Carcinoma

Similarity Score12%

Michael B Gill

Power Life Sciences Inc.

105 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungSmall Cell Lung Carcinoma

Similarity Score12%

David S Schrump, M.D.

National Cancer Institute (NCI)

21 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungMesothelioma, Malignant

Similarity Score12%

Jason Wu

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

31 trials

Shared therapeutic areas:

Small Cell Lung CarcinomaCarcinoma, Non-Small-Cell Lung

Similarity Score12%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

74 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell Lung

Similarity Score6%

Corey J. Langer, MD

Fox Chase Cancer Center

16 trials

Shared therapeutic areas:

Mesothelioma, Malignant

Similarity Score6%

Sabine Hazan, MD

ProgenaBiome

41 trials

Shared therapeutic areas:

Mesothelioma, Malignant

Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT04173338Phase 1PrincipalInvestigator

Cabozantinib With Pemetrexed in Advanced Non-small Cell Lung Cancer, Urothelial Cancer and Malignant Mesothelioma

Malignant MesotheliomaNon Small Cell Lung CancerNon-squamous Non-small-cell Lung Cancer+1 more

Terminated

NCT04173325Phase 1PrincipalInvestigator

Feasibility and Safety Study of Nivolumab With Irinotecan for Small Cell Lung Cancer

Small Cell Lung CarcinomaSmall-cell Lung Cancer

Terminated

All 2 trials loaded